Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
70
RLAY Quote, Financials, Valuation and Earnings
Last price:
$10.16
Seasonality move
:
-27.21%
Day range:
$9.55 - $10.25
52-week range:
$1.78 - $11.43
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
113.41x
P/B ratio:
3.10x
Volume:
2.7M
Avg. volume:
2.5M
1-year change:
218.18%
Market cap:
$1.8B
Revenue:
$15.4M
EPS (TTM):
-$1.61
Earnings Data
Next earnings date for RLAY
May 04
2026
Most recent earnings per share
-$0.32
Beat by $0.08
(Feb 26/2026)
Consensus Estimate
-$0.40
(Feb 26/2026)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RLAY Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q1 | $3.4M | -- | -- | -$0.36 | -- |
| 02/26/2026 | Q4 | $4.3M | $7M | -$0.32 | -$0.40 | $0.08 |
| 11/06/2025 | Q3 | $160K | -- | -$0.43 | -$0.42 | -$0.01 |
| 08/07/2025 | Q2 | $75K | $677K | -$0.41 | -$0.47 | $0.06 |
| 05/05/2025 | Q1 | $11.1K | $7.7M | -$0.46 | -$0.48 | $0.02 |
| 02/26/2025 | Q4 | $5.5M | -- | -$0.45 | -$0.55 | $0.09 |
| 11/06/2024 | Q3 | $80K | -- | -$0.63 | -$0.78 | $0.16 |
| 08/06/2024 | Q2 | $88.9K | -- | -$0.69 | -$0.73 | $0.03 |
| 05/02/2024 | Q1 | $109.1K | $10M | -$0.62 | -$0.69 | $0.07 |
| 02/22/2024 | Q4 | $610K | -- | -$0.67 | -$0.77 | $0.10 |
| 11/02/2023 | Q3 | $412K | $25.2M | -$0.54 | -$0.86 | $0.32 |
| 08/08/2023 | Q2 | -- | $119K | -$0.81 | -- | -- |
| 05/04/2023 | Q1 | -- | $226K | -$0.78 | -- | -- |
| 02/23/2023 | Q4 | -- | $253K | -$0.56 | -- | -- |
| 11/03/2022 | Q3 | -- | $344K | -$0.76 | -- | -- |
| 08/04/2022 | Q2 | -- | $365K | -$0.71 | -- | -- |
| 05/05/2022 | Q1 | -- | $419K | -$0.57 | -- | -- |
| 02/24/2022 | Q4 | -- | $567K | -$0.62 | -- | -- |
| 11/10/2021 | Q3 | -- | $666K | -$0.66 | -- | -- |
| 08/12/2021 | Q2 | -- | $844K | -$2.10 | -- | -- |
| 05/13/2021 | Q1 | -- | $952K | -$0.47 | -- | -- |
| 03/25/2021 | Q4 | -- | $82.7M | $0.39 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$2.38 | -- | -- |
| 08/27/2020 | Q2 | -- | -- | -$0.30 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.28 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.27 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.22 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.19 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.16 | -- | -- |
Relay Therapeutics, Inc. Earnings Questions
-
How Much did Relay Therapeutics, Inc. Generate in Revenue Last Quarter?
Relay Therapeutics, Inc. reported $7M worth of top line sales in its most recent quarter.
-
Did Relay Therapeutics, Inc. Beat Earnings Last Quarter?
Relay Therapeutics, Inc. announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.40 per share.
-
Is Relay Therapeutics, Inc. Profitable?
Relay Therapeutics, Inc. reported $6.4M that represents $0.04 per share over the last quarter.
-
What is the Analyst Consensus for Relay Therapeutics, Inc. EPS Next Year?
Relay Therapeutics, Inc.'s earnings are forecast to decrease from -$1.61 per share to -$1.74 per share next year representing a decrease of -5.9%.
-
When is Relay Therapeutics, Inc.'s Earnings Date?
Relay Therapeutics, Inc.'s next earnings date is May 4, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is up 17.92% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is up 16.05% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is up 14.97% over the past day.
